[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541798":3},{"organization":4,"armGroups":7,"interventions":40,"overallOfficials":69,"centralContacts":73,"locations":80,"responsibleParty":97,"collaborators":78,"id":101,"slug":102,"hasResults":103,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":78,"eligibilityCriteria":107,"healthyVolunteers":103,"sex":108,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":78,"studyType":114,"phases":115,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":82,"whyStopped":78,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Dalian Municipal Central Hospital","OTHER",[8,14,19,24,30,35],{"label":9,"type":10,"description":11,"interventionNames":12},"Ephedrine-Propofol","EXPERIMENTAL","receive ephedrine 0.15mg\u002Fkg (configured concentration 6mg\u002FmL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[13],"Drug: Ephedrine-P",{"label":15,"type":10,"description":16,"interventionNames":17},"Phenylephrine-propofol","receive phenylephrine 2.5ug\u002Fkg(configured concentration 100ug\u002FmL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[18],"Drug: Phenylephrine-P",{"label":20,"type":10,"description":21,"interventionNames":22},"Norepinephrine-propofol","receive norepinephrine 0.2ug\u002Fkg(configured concentration 8μg\u002Fml) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[23],"Drug: Norepinephrine-P",{"label":25,"type":26,"description":27,"interventionNames":28},"Ephedrine-sevoflurane","ACTIVE_COMPARATOR","receive Ephedrine 0.15mg\u002Fkg(configured concentration 6mg\u002FmL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[29],"Drug: Ephedrine-S",{"label":31,"type":26,"description":32,"interventionNames":33},"Phenylephrine-sevoflurane","receive phenylephrine 2.5ug\u002Fkg(configured concentration 80ug\u002FmL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[34],"Drug: Phenylephrine-S",{"label":36,"type":26,"description":37,"interventionNames":38},"Norepinephrine-sevoflurane","receive norepinephrine 0.2ug\u002Fkg(configured concentration 8ug\u002FmL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.",[39],"Drug: Norepinephrine-S",[41,48,52,56,61,65],{"type":42,"name":43,"description":44,"armGroupLabels":45,"otherNames":46},"DRUG","Ephedrine-P","after induction of anesthesia, use total intravenous anesthesia maintained with propofol",[9],[47],"vasopressor",{"type":42,"name":49,"description":44,"armGroupLabels":50,"otherNames":51},"Phenylephrine-P",[15],[47],{"type":42,"name":53,"description":44,"armGroupLabels":54,"otherNames":55},"Norepinephrine-P",[20],[47],{"type":42,"name":57,"description":58,"armGroupLabels":59,"otherNames":60},"Ephedrine-S","after induction of anesthesia, use inhalation anesthesia maintained with sevoflurane",[25],[47],{"type":42,"name":62,"description":58,"armGroupLabels":63,"otherNames":64},"Phenylephrine-S",[31],[47],{"type":42,"name":66,"description":58,"armGroupLabels":67,"otherNames":68},"Norepinephrine-S",[36],[47],[70],{"name":71,"affiliation":5,"role":72},"Hong Fang, MD","STUDY_CHAIR",[74],{"name":75,"role":76,"phone":77,"phoneExt":78,"email":79},"Liping Han, MD, MSc","CONTACT","86-411-84412001",null,"han651310@163.com",[81],{"facility":5,"status":82,"city":83,"state":84,"zip":85,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":93,"contacts":94},"RECRUITING","Dalian","Liaoning","116033","China","CN",{"type":89,"coordinates":90},"Point",[91,92],121.60222,38.91222,{"lat":92,"lon":91},[95],{"name":96,"role":76,"phone":78,"phoneExt":78,"email":78},"Liping Han, M.D.",{"type":98,"investigatorFullName":99,"investigatorTitle":100,"investigatorAffiliation":5,"oldNameTitle":78,"oldOrganization":78},"PRINCIPAL_INVESTIGATOR","Liping Han","Professor & Vice Director","100541798","phase-4-a-prospective-study-of-vasopressor-on-cerebral-oxygenation-during-general-anesthesia-100541798",false,"NCT06334549","A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia","Effects of Vasopressor on Cerebral Oxygenation During General Anesthesia in Abdominal Surgery","Inclusion Criteria:\n\n* ASA I-III, age 18-80 years\n* Elective abdominal surgery\n* Signed informed consent\n\nExclusion Criteria:\n\n* ASA≥IV\n* Preoperative unstable blood hemodynamics\n* Allergy to ephedrine, phenylephrine or norepinephrine\n* Decrease in MAP \\\u003C20%\n* Severe cardiovascular disorder","ALL","18 Years","80 Years",{"count":112,"type":113},180,"ESTIMATED","INTERVENTIONAL",[116],"PHASE4","The purpose of this study is to investigate whether norepinephrine(N), phenylephrine(P) or ephedrine(E) have different effect on cerebral oxygenation in abdominal surgery with propofol or sevoflurane.",[119],"Hypotension Drug-Induced",[121,122,123,124,125,126,127,128,129,130,131],"Abdominal surgery","ephedrine","phenylephrine","norepinephrine","cerebral oxygen saturation","MAP","CO","General anesthesia","Propofol","Sevoflurane","Hypotension Drug-induced","2024-11-04",{"date":134,"type":135},"2024-11-06","ACTUAL",{"date":137,"type":135},"2024-03-05",{"date":139,"type":113},"2025-12-05",{"name":5,"class":6},1]